Facebook
Linkedin
Pinterest
Reddit
Twitter
Medical Devices
Biotechnology
Clinical Trials
Mergers & Acquisitions
Funding
FDA
Industry Expert Articles
Other News
Market Reports
Executives
Hospitals
Imaging
Ultrasound
Health
Articles
Search
Central Nervous System Diseases
QYNAPSE Novel Imaging Software for Central Nervous System Diseases Receives FDA Clearance
QyScore® allows automated quantification of a broad portfolio of Magnetic Resonance Imaging markers that are key to support early diagnosis and clinical monitoring of neurodegenerative disorders notes QYNAPSE.
February 3, 2020